Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Sep;35(5):332-338.
doi: 10.1111/phpp.12479. Epub 2019 May 20.

Narrowband ultraviolet B phototherapy improves quality of life of psoriasis and atopic dermatitis patients up to 3 months: Results from an observational multicenter study

Liisa Väkevä  1 , Sirkka Niemelä  2 , Meri Lauha  3 , Rafael Pasternack  3 , Anna Hannuksela-Svahn  4 , Anna Hjerppe  5 , Adrienn Joensuu  6 , Minna Soronen  7 , Lasse Ylianttila  8 , Riikka Pastila  8 , Hannu Kautiainen  9   10 , Erna Snellman  3   11 , Mari Grönroos  12 , Toni Karppinen  3   11   12
Affiliations
Clinical Trial

Narrowband ultraviolet B phototherapy improves quality of life of psoriasis and atopic dermatitis patients up to 3 months: Results from an observational multicenter study

Liisa Väkevä et al. Photodermatol Photoimmunol Photomed. 2019 Sep.

Abstract

Background/purpose: Narrowband UVB phototherapy is a common treatment modality in psoriasis and atopic dermatitis, but evidence of its actual effect in clinical setting is sparse. Our aim was to assess the effectiveness and costs of narrowband UVB phototherapy in psoriasis and atopic dermatitis in clinical setting.

Methods: We observed 207 psoriasis patients and 144 atopic dermatitis patients in eight centers. SAPASI, PO-SCORAD, and VAS measures were used at baseline, at the end, and 3 months after the narrowband UVB phototherapy course. Quality of life was measured using Dermatology Life Quality Index (DLQI), and costs were assessed using a questionnaire.

Results: In both psoriasis and atopic dermatitis, the DLQI and Self-Administrated PASI (SAPASI)/Patient-Oriented SCORAD (PO-SCORAD) improved significantly and the results remained improved for at least 3 months in both groups. Alleviation of pruritus correlated with better quality of life in both patient groups. We reported slight redness and burning side effects which were due to lack of MED testing. Self-administered tools proved to be useful in evaluating pruritus and severity of the disease in psoriasis and atopic dermatitis. Mean patient costs were 310 € and 21 hours of time, and mean costs for the healthcare provider were 810 €.

Conclusion: In psoriasis, narrowband UVB is a very efficient treatment in clinical setting, whereas in atopic dermatitis, more studies are needed to determine the best dosage.

Keywords: Dermatology Life Quality Index; Patient-Oriented SCORAD; Psoriasis Area and Severity Index; Scoring of Atopic Dermatitis; Self-Administrated PASI.

PubMed Disclaimer

References

REFERENCES

    1. Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401-407.
    1. Darne S, Leech SN, Taylor A. Narrowband ultraviolet B phototherapy in children with moderate-to-severe eczema: a comparative cohort study. Br J Dermatol. 2015;170:150-156.
    1. Mrowietz U, Chouela EN, Mallbris L, et al. Pruritus and quality of life in moderate to severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study. J Eur Acad Dermatol Venereol. 2015;29:1114-1120.
    1. Gerritsen FM, Brouwer M, Limpens J, Spuls PI. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research. Br J Dermatol. 2014;170:501-513.
    1. Al Robaee AA, Alzolibani AA. Narrowband ultraviolet B phototherapy improves the quality of life in patients with psoriasis. Saudi Med J. 2011;32:603-606.

LinkOut - more resources